Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome
ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.16, sa.12, ss.953-958, 2016 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 16 Sayı: 12
- Basım Tarihi: 2016
- Doi Numarası: 10.14744/anatoljcardiol.2016.6933
- Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.953-958
- Anahtar Kelimeler: metabolic syndrome, cardiovascular risk factors, hs-CRP, YKL-40, inflammation, PERIPHERAL ARTERIAL-DISEASE, ALL-CAUSE MORTALITY, C-REACTIVE PROTEIN, INSULIN-RESISTANCE, INFLAMMATORY BIOMARKERS, LYMPHOCYTE RATIO, PLASMA YKL-40, MARKER, RISK, ATHEROSCLEROSIS
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Gazi Üniversitesi Adresli: Evet
Özet
Objective: Metabolic syndrome (MS) is defined by a cluster of interdependent physiological, biochemical, and clinical risk factors and linked to a state of chronic inflammation. YKL-40 is known as an inflammatory glycoprotein, which is secreted by various cell lines during inflammation. Thus, we aimed to assess the association of serum YKL-40 levels with the presence and severity of MS.